{"id":652651,"date":"2026-06-22T18:46:16","date_gmt":"2026-06-22T18:46:16","guid":{"rendered":"https:\/\/www.newsbeep.com\/uk\/652651\/"},"modified":"2026-06-22T18:46:16","modified_gmt":"2026-06-22T18:46:16","slug":"glp-1-use-set-to-double-following-wegovy-pill-approval-news","status":"publish","type":"post","link":"https:\/\/www.newsbeep.com\/uk\/652651\/","title":{"rendered":"GLP-1 use set to double following Wegovy pill approval | News"},"content":{"rendered":"<p class=\"picture\"><img fetchpriority=\"high\" decoding=\"async\" alt=\"Pill tablet Semaglutide tirzepatide WeGovy GLP-1 GLP 1 Mounjaro Ozempic GettyImages-2272396067\" src=\"https:\/\/www.newsbeep.com\/uk\/wp-content\/uploads\/2026\/06\/398164_pilltabletsemaglutidetirzepatidewegovyglp1glp1mounjaroozempicgettyimages2272396067_889932.jpg\"   loading=\"eager\" class=\"lazyloaded\" width=\"6048\" height=\"4032\"\/><\/p>\n<p dir=\"ltr\">The number of adults using GLP-1 weight-loss drugs could more than double to seven million following the approval of pill format medication, according to PwC.<\/p>\n<p dir=\"ltr\">Adoption among adults could leap to two-and-a-half times current levels to 13%, the consultancy said in research released this morning.<\/p>\n<p dir=\"ltr\">Just under a tenth (9%) of UK adults have ever used the appetite-suppressing medication, which has exploded in popularity in recent years as an aid to weight loss.\u00a0<\/p>\n<p dir=\"ltr\">An additional 18% of consumers now say they would consider using the jab or pill \u2013 representing a massive potential change in shopping habits.<\/p>\n<p dir=\"ltr\">The vast majority (70%) of those using the drugs spent less on snacks and confectionery, and 60% spent less on sugary drinks.\u00a0But 60% of users reported increasing their fresh food budget, and 54% said they spent more on high-protein foods. Four in 10 (40%) said they spent more on vitamins and supplements.<\/p>\n<p dir=\"ltr\">The drugs have already <a href=\"https:\/\/www.thegrocer.co.uk\/news\/weight-loss-drugs-wipe-780m-off-britains-grocery-sales\/719985.article\" target=\"_blank\" rel=\"nofollow noopener\">wiped off \u00a3780m from household spend<\/a> in the year to 28 February, according to NIQ statistics released in early June \u2013 equivalent to \u00a3418 less a year for each household with a GLP-1 user.<\/p>\n<p dir=\"ltr\">GLP-1s are now the \u201cmost consumerised medication today\u201d, said PwC UK head of retail and partner in the firm\u2019s Strategy&amp; consulting wing Jacqueline Windsor.<\/p>\n<p dir=\"ltr\">Growing awareness and adoption of the drugs means that patients are increasingly picky, considering brand, value, efficacy, convenience and trust when choosing their medication.<\/p>\n<p dir=\"ltr\">Wegovy was the first brand to win <a href=\"https:\/\/www.thegrocer.co.uk\/news\/weight-loss-pills-granted-uk-regulatory-approval\/720064.article\" target=\"_blank\" rel=\"nofollow noopener\">regulatory approval for pill-format drugs in the UK<\/a> last week, following their approval in January 2026 in the US.<\/p>\n<p dir=\"ltr\">\u201cClearly likely to be more accessible\u201d for many consumers compared to jabs, the pill\u2019s approval represented a \u201cnotable moment for the UK food system\u201d, according to Shore Capital VC Clive Black.<\/p>\n<p dir=\"ltr\">Retailers have prepared for high demand for the new-format drugs, with Superdrug asking customers to register their interest ahead of product launch.<\/p>\n<p dir=\"ltr\">Windsor added that users expressed \u201crenewed confidence and energy\u201d that shaped their demand for nutritious foods, fitness routines and fresh wardrobes.<\/p>\n<p dir=\"ltr\">\u201cThat represents a basket reallocation rather than a reduction of spend,\u201d she said.<\/p>\n<p dir=\"ltr\">\u201cWho your GLP-1 customers are, and how your category\u202fchanges, will dictate how brands and retailers compete.\u201d\u00a0<\/p>\n<p>$(document).ready(function() {<br \/>\nif (window.location.pathname == &#8216;\/advertise&#8217;) {<br \/>\n$.getScript(&#8220;https:\/\/tag.clearbitscripts.com\/v1\/pk_6c1cac1dc287e45bfaab20867b193dcb\/tags.js&#8221;);<br \/>\nconsole.log(&#8220;Clearbit Loaded&#8221;);<br \/>\n}<br \/>\n});<\/p>\n","protected":false},"excerpt":{"rendered":"The number of adults using GLP-1 weight-loss drugs could more than double to seven million following the approval&hellip;\n","protected":false},"author":2,"featured_media":652652,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[42],"tags":[102,6591,56,54,55],"class_list":["post-652651","post","type-post","status-publish","format-standard","has-post-thumbnail","category-medication","tag-health","tag-medication","tag-uk","tag-united-kingdom","tag-unitedkingdom"],"_links":{"self":[{"href":"https:\/\/www.newsbeep.com\/uk\/wp-json\/wp\/v2\/posts\/652651","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.newsbeep.com\/uk\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.newsbeep.com\/uk\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/uk\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/uk\/wp-json\/wp\/v2\/comments?post=652651"}],"version-history":[{"count":0,"href":"https:\/\/www.newsbeep.com\/uk\/wp-json\/wp\/v2\/posts\/652651\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/uk\/wp-json\/wp\/v2\/media\/652652"}],"wp:attachment":[{"href":"https:\/\/www.newsbeep.com\/uk\/wp-json\/wp\/v2\/media?parent=652651"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.newsbeep.com\/uk\/wp-json\/wp\/v2\/categories?post=652651"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.newsbeep.com\/uk\/wp-json\/wp\/v2\/tags?post=652651"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}